Get started
Invesco Biotechnology & Genome ETFInvesco Biotechnology & Genome ETFInvesco Biotechnology & Genome ETF

Invesco Biotechnology & Genome ETF

No trades
See on Supercharts
Overview Analysis
Holdings
News Ideas Discussions Technicals Seasonals Options

Invesco Biotechnology & Genome ETF holdings


As of June 5, 2025
Symbol
Weight %
Shares
Shares Chg %
1M
Market value
Market value Chg %
1M
A
ALNYAlnylam Pharmaceuticals, Inc
5.16%
‪‪38.01 K‬‬
—
‪‪11.71 M‬‬USD
—
R
RPRXRoyalty Pharma Plc Class A
5.02%
‪‪337.28 K‬‬
+76.04%
‪‪11.38 M‬‬USD
+80.04%
A
AMGNAmgen Inc.
5.00%
‪‪39.45 K‬‬
+5.15%
‪‪11.33 M‬‬USD
+7.79%
U
UTHRUnited Therapeutics Corporation
4.94%
‪‪35.02 K‬‬
+5.69%
‪‪11.20 M‬‬USD
+13.13%
G
GILDGilead Sciences, Inc.
4.92%
‪‪101.07 K‬‬
−4.83%
‪‪11.16 M‬‬USD
+2.25%
I
ILMNIllumina, Inc.
4.85%
‪‪133.66 K‬‬
+8.06%
‪‪10.99 M‬‬USD
+13.70%
V
VRTXVertex Pharmaceuticals Incorporated
4.84%
‪‪24.72 K‬‬
—
‪‪10.97 M‬‬USD
—
B
BMRNBioMarin Pharmaceutical Inc.
4.63%
‪‪189.74 K‬‬
+109.20%
‪‪10.49 M‬‬USD
+86.31%
B
BPMCBlueprint Medicines Corp.
3.39%
‪‪60.10 K‬‬
−15.11%
‪‪7.69 M‬‬USD
+6.62%
P
PTGXProtagonist Therapeutics, Inc.
3.08%
‪‪129.53 K‬‬
−29.65%
‪‪6.97 M‬‬USD
−14.49%
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.